Bluevac-3
Inactivated bluetongue virus, serotype 3, strain BTV-3/NET2023
Available in:
- 250mls vial
Cattle
For active immunisation of cattle to reduce the viraemia against the serotype 3 of the bluetongue virus.
Onset of immunity: 21 days after completion of the primary vaccination scheme.
Duration of immunity: not established yet.
Sheep
For active immunisation of sheep to reduce the viraemia, preventing mortality and to reduce clinical signs caused by the serotype 3 of the bluetongue virus.
Onset of immunity: 21 days after completion of the primary vaccination scheme.
Duration of immunity: not established yet.
Fertility: The safety and efficacy of the vaccines has not been established in breeding males (sheep and cattle).
Target species:
-
Cattle
-
Sheep
How to use
Administration – Subcutaneous use.
- Primary vaccination, can be used during pregnancy in ewes and cows.
- Cattle from 2 month of age: Administer two doses of 4 ml subcutaneously 3 weeks apart
- Sheep from 2 months of age: Administer two doses of 2 mL subcutaneously 3 weeks apart
- Revaccination not yet established
- Withdrawal: Zero days
Prescription decisions are for the person issuing the prescription alone. Please refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications. Further information is available from the SPC or on the datasheet or on request.
Legal Category: UK POMV

Why choose
Bluevac
In cattle Bluevac-3
Reduces the viraemia (the presence of virus in the blood)
In sheep Bluevac-3
Reduces the viraemia, preventing mortality and reduces clinical signs caused by the serotype 3 of the bluetongue virus
Convenience
Can be administered during pregnancy to ewes and female cattle
Pack options
Zero milk and meat withdrawal
Are you a farmer or a vet professional?
This page is for veterinary health care providers and professional keepers of farm livestock in the UK